Page last updated: 2024-08-25

ropivacaine and Familial Nonmedullary Thyroid Cancer

ropivacaine has been researched along with Familial Nonmedullary Thyroid Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Liu, Q; Qin, A; Wang, J	1

Other Studies

1 other study(ies) available for ropivacaine and Familial Nonmedullary Thyroid Cancer

Article	Year
Ropivacaine inhibits proliferation, invasion, migration and promotes apoptosis of papillary thyroid cancer cells via regulating ITGA2 expression. Drug development research, 2020, Volume: 81, Issue:6 Topics: Antineoplastic Agents; Apoptosis; Cell Line; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Integrin alpha2; Ropivacaine; Thyroid Cancer, Papillary; Thyroid Neoplasms	2020

Article

Year

Ropivacaine inhibits proliferation, invasion, migration and promotes apoptosis of papillary thyroid cancer cells via regulating ITGA2 expression.

Drug development research, 2020, Volume: 81, Issue:6

Topics: Antineoplastic Agents; Apoptosis; Cell Line; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Integrin alpha2; Ropivacaine; Thyroid Cancer, Papillary; Thyroid Neoplasms

2020